US FDA Approves Bladder Cancer Treatment Inlexzo from J&J
The U.S. Food and Drug Administration has granted approval to Johnson & Johnson’s drug delivery system for a specific type of bladder cancer. The...
Eli Lilly Unveils Lilly TuneLab for AI-driven Drug Discovery
Eli Lilly and Company has officially introduced the Lilly TuneLab AI platform, a new artificial intelligence and machine learning system designed to give biotechnology...
FDA Approves Recombinant VWF Treatment in Pediatric Patients
The US Food and Drug Administration (FDA) has expanded the indication for recombinant von Willebrand factor (VWF), marketed as Vonvendi, to include children with...
Novartis and Argo Signs Deal of up to $5.2b for Heart Drugs
Swiss pharmaceutical leader Novartis has entered into a cardiovascular drug licensing deal valued at up to $5.2 billion with China-based Argo Biopharmaceutical. The deal...
Mod GRF 1-29 Peptide: Investigating Its Potential in Scientific Research
The Mod GRF 1-29 peptide has garnered attention in scientific research due to its hypothesized role in regulating growth hormone. As a modified analog...
MGI Tech and JCBio Advance Multi-Omics with DCS Lab Project
MGI Tech Co., Ltd., a developer of advanced life sciences technologies, and JCBio Co., Ltd., a biotechnology company in South Korea, have entered into...
Novartis and Arrowhead Sign Deal to Advance Parkinson’s Drug
Novartis has renewed its focus on Parkinson’s disease through a significant collaboration with Arrowhead Pharmaceuticals, marking another strategic step into neuroscience drug development. The...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...